The clinical selection of empiric antibiotic therapy with meropenem versus imipenem-cilastatin in critical patients with the risk or history of seizures on evidence-based analysis
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: WU, Hui-Ju (Kaohsiung Municipal Hsiaokang Hospital, Pharmacy, Kaohsiung, China Taiwan)
- Co-author(s): Chen, Hsiu-Shan (Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, China Taiwan)
:Carbapenems were a choice by broad spectrum in serious bacterial infections of critical patients.In the past,meropenem was considered as effective as imipenem-cilastatin and had more less incidence of seizures.But some studies showed the different results.
:This study was to investigate if meropenem was better than.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.